The burgeoning need for molecular scientists in the pharmaceutical industry
is fueled by the evolving nature of chemistry, biology, and physics, the a
pplications of which are best assisted by an understanding of the use of in
formatics. The legitimate common interests of society, government, industry
, and higher education systems dictate a fresh look at curricular issues as
sociated with the training of molecular scientists, i.e. chemists. Some sug
gestions are offered.